250mg Geftinat Gefitinib Tablets About
Discover the Best-seller 250mg Geftinat Gefitinib Tablets, a Must-have oral anti-cancer therapy remarked for its uncommon efficacy in treating pancreatic cancer. This First-string prescription medication features a targeted EGFR inhibitor formula, delivering 250mg Gefitinib per round, imprinted tablet. With a pack size of 30 tablets, each white to off-white tablet is odorless and designed for adults. Securely packaged in a box, this hot deal offers a remarkable treatment route with a 24-month shelf life. Geftinat is trusted by exporters, suppliers, and traders across India for optimal patient care.
Competitive Edge & Applications Beyond Pancreatic Cancer
250mg Geftinat Gefitinib Tablets offer unparalleled value not just as a frontline anti-cancer therapy for pancreatic cancer, but also in treating select other EGFR-positive malignancies, pending medical guidance. Benefiting from superior targeting, these tablets maximize tumor inhibition while limiting systemic side effects-a competitive advantage. Their formulation ensures consistent results, making them an advantageous choice for oncologists and adult patients requiring an uncommon, effective targeted therapy in cancer management.
Supply, Delivery & Seamless Domestic Transportation
With a robust supply ability, 250mg Geftinat Gefitinib Tablets are available to meet steady domestic market demand. Shipped goods are handled via secure transportation channels, ensuring timely and intact delivery. Most orders are processed promptly, with reliable delivery times in line with industry standards. Our sample policy accommodates healthcare professionals seeking product assurance before large-scale procurement, illustrating our commitment to quality and service in the Indian pharmaceutical sector.
FAQ's of 250mg Geftinat Gefitinib Tablets:
Q: How should 250mg Geftinat Gefitinib Tablets be taken?
A: These tablets are administered orally, once daily or as prescribed by your oncologist, and should be swallowed whole with water.
Q: What makes Geftinat Gefitinib Tablets a must-have in cancer therapy?
A: Geftinat stands out for its targeted approach as an EGFR inhibitor, providing effective tumor suppression with reduced side effects compared to traditional chemotherapy.
Q: When can patients expect to see results from Geftinat Gefitinib therapy?
A: Results vary depending on the individual and cancer stage, but most patients may notice clinical improvements after some weeks of continuous, prescribed use.
Q: Where are Geftinat Gefitinib Tablets exported from?
A: These tablets are manufactured and distributed throughout India, with wide availability for export, supply, and trading in regulated markets.
Q: What is the process for storing Geftinat tablets?
A: Store the tablets below 30C in a dry, odourless place; make sure the box remains sealed to maintain efficacy throughout its 24-month shelf life.
Q: What are the benefits of Geftinat's imprinted round tablet design?
A: The imprinted, round shape enhances identification and dosing accuracy, making it patient-friendly and supporting healthcare compliance.
Send Inquiry
